Clinical trial
Strategic Management to Optimize Response To Cardiac Resynchronization Therapy
NCT03089281 is registered in ClinicalTrials.gov with Boston Scientific Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Strategic Management to Optimize Response To Cardiac Resynchronization Therapy
- Lead sponsor
- Boston Scientific Corporation
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- August 1, 2017
- Completion date
- September 15, 2020
- Enrollment
- 699 (actual)
- Sites
- 72
Conditions
As the registry lists them; a condition with its own page is linked.